The radiation oncology treatment planning software market has seen considerable growth due to a variety of factors.
• In recent times, there has been a considerable growth in the radiation oncology treatment planning software market size. The market, which was valued at $2.3 billion in 2024, is expected to appreciate to $2.52 billion in 2025, marking a compound annual growth rate (CAGR) of 9.6%.
This surge during the historic period is largely due to increasing demand for advanced and efficient cancer therapies, a burgeoning interest in individualized medicine, development of healthcare facilities, escalating investments in oncology care, and a swift rise in the aged population.
The radiation oncology treatment planning software market is expected to maintain its strong growth trajectory in upcoming years.
• The market size for radiation oncology treatment planning software is predicted to witness robust expansion in the upcoming years, inflating to $3.58 billion by 2029 with a CAGR of 9.2%.
This anticipated growth rate across the forecasted time frame can be associated with factors such as the escalating prevalence of cancer worldwide, governmental efforts and financial aid, the implementation of electronic health records (EHRs), rising demand for creative cancer treatment methodologies, and an increasing need for exact and accurate diagnoses. Trending prospects during the forecast span comprise rising incorporation of AI/ML techniques into cancer treatments, progression in the healthcare IT industry, an escalating focus on inventing fresh product development strategies, boosting demand for innovative cancer treatments, and soaring requirement for precise diagnostic procedures.
The radiation oncology treatment planning software market is anticipated to grow, spurred by the increasing rates of cancer prevalence. This rise in cancer cases can be attributed to several factors such as an aging populace, higher exposure to risk elements like tobacco consumption, poor dietary habits, and environmental pollutants, advancement in early detection and diagnostic technologies, and enhanced cancer survival rates. The planning software in radiation oncology uses imaging data for accurate targeting of tumors and protecting healthy tissues. It amplifies the effectiveness of the treatment and reduces side effects by creating comprehensive 3D models and improving the dose and beam angles. For example, in January 2024, the American Cancer Society, a non-profit US organization dedicated to cancer eradication, documented 108,270 skin cancer cases, indicating a 3.2% rise from 104,930 cases in 2023. Therefore, the surge in cancer prevalence is accelerating the growth of the radiation oncology treatment planning software market.
The radiation oncology treatment planning software market covered in this report is segmented –
1) By Type: Patient Information Systems, Treatment Planning System
2) By Therapy Type: Stereotactic Radiosurgery (SRS), Three-Dimensional Conformal Radiation Therapy (3D CRT), Brachytherapy, Stereotactic Body Radiotherapy (SBRT), Intensity Modulated Radiation Therapy (IMRT), Volumetric Modulated Arc Therapy (VMAT), Other Therapy Types
3) By End-User: Hospitals And Physician’s Offices, Research Centers, Government Institutions, Cancer Treatment Centers, Other End-Users
Subsegments:
1) By Patient Information Systems: Patient Registration Systems, Appointment Scheduling Systems, Electronic Health Records (EHR) Integration, Patient Portals, Treatment History Management
2) By Treatment Planning System: 3D Treatment Planning Software, Intensity-Modulated Radiation Therapy (IMRT) Planning, Stereotactic Body Radiation Therapy (SBRT) Planning, Adaptive Radiation Therapy Planning, Brachytherapy Planning Software, Clinical Decision Support Tools
Key industry players in the radiation oncology treatment planning software market are channeling their efforts towards introducing advanced functionalities, like centralized data management, to boost precision in tumor targeting and simplify workflow procedures. The incorporation of centralized data management significantly enhances efficiency by amalgamating patient records, treatment information, and imaging outcomes into a single, easy-to-access platform, promoting streamlined workflows and better decision-making capacity. To illustrate, in June 2024, Accuray Incorporated, a company that specializes in radiation therapy solutions from the US, introduced the Accuray Precision Treatment Planning System (TPS), which was sanctioned by the Chinese National Medical Products Administration (NMPA). It capably formulates and modifies treatment plans taking into account the changes in the tumor's size, shape, and position. The system allows for real-time modifications, improving precision by accounting for shifts in tumors and benign tissues. It can be perfectly merged with the Tomo C system and ensures accurate dose regulation via helical imaging and radiation administration. The proprietary technology it embodies guarantees the conformity of the radiation dosage to the tumor while curtailing the exposure to benign tissue.
Major companies operating in the radiation oncology treatment planning software market are include:
•Siemens Healthineers AG
• Koninklijke Philips N.V.
• GE Healthcare Technologies Inc.
• Varian Medical Systems Inc.
• Elekta AB
• Brainlab AG
• IBA Worldwide SA
• Accuracy Incorporated
• Canon Medical Systems Corporation
• ViewRay Inc.
• RaySearch Laboratories AB
• Vision RT Ltd.
• C-RAD
• LAP GmbH Laser Applikationen
• ZAP Surgical Systems Inc.
• MVision AI
• DOSIsoft SA
• Mirada Medical Ltd.
• Xcision Medical Systems LLC
• Radformation Inc.
• Synaptiq
North America was the largest region in the radiation oncology treatment planning software market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the radiation oncology treatment planning software market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.